Posted on


HemoGAD Technologies proof-of-concept study to prove that SAlivary Ferritin (SAF) can be used as an accurate and quantitative marker for monitoring the bodies iron stores concludes in a few weeks time. The latest indications from our fourth round of matched sample (blood and saliva) testing, using an assay, are extremely positive and the final report is being compiled over the next week or so.

This is very exciting news for HH and IDA patients, as this technology will form the foundation for us to develop a non-intrusive home test, enabling patients in maintenance to monitor themselves at home. Follow us on social media or register on our website for regular updates on our Guardian Angel Device (GAD).